Fil LTD Axsome Therapeutics, Inc. Transaction History

Fil LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $202,604 - $694,613	-10,176 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$55.91 - $81.44 $564,746 - $822,625	10,101 Added 13468.0%	10,176 $576,000
Q3 2020 Nov 13, 2020	BUY	$68.34 - $85.84 $2,733 - $3,433	40 Added 114.29%	75 $5,000
Q2 2020 Aug 13, 2020	SELL	$49.87 - $98.69 $13.2 Million - $26.2 Million	-265,050 Reduced 99.99%	35 $3,000
Q1 2020 May 14, 2020	BUY	$41.2 - $101.31 $2.72 Million - $6.68 Million	65,934 Added 33.11%	265,085 $15.6 Million
Q4 2019 Feb 07, 2020	SELL	$16.71 - $106.24 $185,514 - $1.18 Million	-11,102 Reduced 5.28%	199,151 $20.6 Million
Q3 2019 Nov 13, 2019	BUY	$20.24 - $29.16 $4.26 Million - $6.13 Million	210,253 New	210,253 $4.26 Million

327

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.